Nitrogenous Heterocyclic Compounds, Pharmaceutical composition with AMPK activity； in vitro； methods； and its use in cardiovascular diseases, Type II diabetes, muscular dystrophy, neurolgicos disorders, inflammatory diseases, among others.
wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.COMPUESTOS DERIVADOS DE PIRIDINAS, CON ACTIVIDAD AMPK； COMPOSICION FARMACEUTICA； Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, DIABETES TIPO II, DISTROFIA MUSCULAR, TRASTORNOS NEUROLÓGICOS, ENFERMEDADES INFLAMATORIAS, ENTRE OTRAS.
